{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:19:57Z","timestamp":1794777597938,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermer\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.enfcle.2026.502530","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:25:15Z","timestamp":1792106715000},"page":"502530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment adherence in chronic lymphocytic leukaemia and chronic myeloid leukaemia: An integrative review"],"prefix":"10.1016","volume":"36","author":[{"given":"Ang\u00e9lica","family":"Aranda-Monta\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Fabrellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Guix-Comellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.enfcle.2026.502530_bib0005","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","article-title":"Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study","volume":"113","author":"Noens","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.enfcle.2026.502530_bib0010","first-page":"3237","article-title":"Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial","volume":"28","author":"Tan","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.enfcle.2026.502530_bib0015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/jan.12978","article-title":"Impact of tailored patient education on adherence of patients with chronic myeloid leukaemia to tyrosine kinase inhibitors: a randomized multicentre intervention study","volume":"72","author":"Kek\u00e4le","year":"2016","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.enfcle.2026.502530_bib0020","series-title":"JBI manual for evidence synthesis [Internet]","article-title":"Systematic reviews of qualitative evidence","author":"Lockwood","year":"2024"},{"key":"10.1016\/j.enfcle.2026.502530_bib0025","series-title":"JBI manual for evidence synthesis [Internet]","year":"2024"},{"key":"10.1016\/j.enfcle.2026.502530_bib0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.enfcle.2026.502530_bib0035","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.enfcle.2026.502530_bib0040","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/JOP.17.00039","article-title":"Improved adherence rates and clinical outcomes of an integrated, closed-loop, pharmacist-led oral chemotherapy management program","volume":"14","author":"Muluneh","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.enfcle.2026.502530_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110847","article-title":"Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia","volume":"124","author":"Cheng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.enfcle.2026.502530_bib0050","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.clml.2018.06.026","article-title":"Effect of adherence-enhancing interventions on adherence to tyrosine kinase inhibitor treatment in chronic myeloid leukemia (TAKE-IT): a quasi-experimental pre-post intervention multicenter pilot study","volume":"18","author":"Leader","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.enfcle.2026.502530_bib0055","doi-asserted-by":"crossref","DOI":"10.4137\/CMO.S32822","article-title":"Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar?","volume":"10","author":"Al-Dewik","year":"2016","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.enfcle.2026.502530_bib0060","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1200\/JCO.2016.67.4184","article-title":"Factors associated with tyrosine kinase inhibitor initiation and adherence among Medicare beneficiaries with chronic myeloid leukemia","volume":"34","author":"Winn","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.enfcle.2026.502530_bib0065","article-title":"Association between the profile of patients with chronic myeloid leukemia and adherence to tyrosine kinase inhibitors","author":"Rodrigues Moreira","year":"2025","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.enfcle.2026.502530_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.farma.2022.11.006","article-title":"Adherencia y calidad de vida en los pacientes con leucemia linfoc\u00edtica cr\u00f3nica tratados con antineopl\u00e1sicos orales","volume":"47","author":"Ochagav\u00eda Sufrategui","year":"2023","journal-title":"Farm Hosp"},{"key":"10.1016\/j.enfcle.2026.502530_bib0075","doi-asserted-by":"crossref","first-page":"HSR25","DOI":"10.6004\/jnccn.2024.7251","article-title":"Impact of adverse events on quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: results from the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) study","volume":"23","author":"Flynn","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.enfcle.2026.502530_bib0080","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3904\/kjim.2021.158","article-title":"Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.enfcle.2026.502530_bib0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41375-023-01888-y","article-title":"Health-related quality of life of patients with resistant\/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial","volume":"37","author":"R\u00e9a","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.enfcle.2026.502530_bib0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.farma.2024.11.009","article-title":"Impacto de la atenci\u00f3n farmac\u00e9utica en la adherencia a los inhibidores de la tirosin-cinasa en la leucemia mieloide cr\u00f3nica","volume":"49","author":"Del Rosario Garc\u00eda","year":"2025","journal-title":"Farm Hosp"}],"container-title":["Enfermer\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2445147926001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2445147926001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:02:51Z","timestamp":1794776571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2445147926001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2445147926001098"],"URL":"https:\/\/doi.org\/10.1016\/j.enfcle.2026.502530","relation":{},"ISSN":["2445-1479"],"issn-type":[{"value":"2445-1479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment adherence in chronic lymphocytic leukaemia and chronic myeloid leukaemia: An integrative review","name":"articletitle","label":"Article Title"},{"value":"Enfermer\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.enfcle.2026.502530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.enfcli.2026.502530","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502530"}}